Table 1 Marginal and conditional estimates for genetic markers at 8q24 independently associated with prostate cancer risk

From: Germline variation at 8q24 and prostate cancer risk in men of European ancestry

Variant IDa

Positionb

Allelec

RAFd

LD clustere

Conditional associationf

Marginal association

OR (95%CI)g

p-value

OR (95%CI)h

p-value

rs1914295

127910317

T/C

0.68

block 1

1.10 (1.08–1.12)

7.30 × 10−25

1.09 (1.07–1.11)

3.07 × 10−21

rs1487240

128021752

A/G

0.74

block 1

1.20 (1.17–1.22)

2.77 × 10−66

1.16 (1.14–1.18)

2.97 × 10−54

rs77541621

128077146

A/G

0.02

block 2

1.85 (1.76–1.94)

2.93 × 10−137

1.83 (1.74–1.92)

4.33 × 10−137

rs190257175

128103466

T/C

0.99

block 2

1.60 (1.42–1.80)

4.28 × 10−15

1.36 (1.22–1.53)

6.90 × 10−8

rs72725879

128103969

T/C

0.18

block 2

1.31 (1.28–1.35)

1.26 × 10−83

1.17 (1.14–1.19)

3.96 × 10−48

rs5013678

128103979

T/C

0.78

block 2

1.10 (1.08–1.13)

1.58 × 10−19

1.20 (1.17–1.22)

4.44 × 10−68

rs183373024

128104117

G/A

0.01

block 2

2.67 (2.43–2.93)

4.89 × 10−95

3.20 (2.92–3.50)

6.60 × 10−138

rs78511380

128114146

T/A

0.92

block 2

1.19 (1.14–1.23)

3.48 × 10−18

0.97 (0.94–1.00)

0.027

rs17464492

128342866

A/G

0.72

block 3

1.16 (1.14–1.18)

3.01 × 10−52

1.17 (1.15–1.19)

9.05 × 10−61

rs6983267

128413305

G/T

0.51

block 4

1.18 (1.16–1.20)

5.68 × 10−84

1.23 (1.21–1.25)

3.15 × 10−135

rs7812894

128520479

A/T

0.11

block 5

1.37 (1.33–1.40)

1.55 × 10−122

1.45 (1.41–1.49)

1.20 × 10−181

rs12549761

128540776

C/G

0.87

block 5

1.21 (1.18–1.24)

1.61 × 10−45

1.28 (1.25–1.31)

1.38 × 10−78

  1. aVariants that remained genome-wide significantly associated with PCa risk (p < 10−8) in the final stepwise model
  2. bChromosome position based on human genome build 37
  3. cRisk allele/reference allele
  4. dRisk allele frequency
  5. eLD clusters were inferred based on recombination hotspots using Haploview 4.229 and defined as previously reported by Al Olama et al.4
  6. fEach variant was incorporated in the stepwise model based on the strength of marginal association from the meta-analysis of OncoArray and iCOGS data
  7. gPer-allele odds ratio and 95% confidence interval adjusted for country, 7(OncoArray)/8(iCOGS) principal components and all other variants in the table
  8. hPer-allele odds ratio and 95% confidence interval adjusted for country and 7(OncoArray)/8(iCOGS) principal components